Acute Leukemia : The Scientist's Perspective and Challenge

This book provides a comprehensive overview of he basic mechanisms underlying areas of acute leukemia, current advances, and future directions in management of this disease. The first section discusses the classification of acute leukemia, taking into account diagnoses dependent on techniques that a...

Full description

Saved in:
Bibliographic Details
Other Authors: Antica, Mariastefania (Editor)
Format: Book Chapter
Published: IntechOpen 2011
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02396naaaa2200289uu 4500
001 doab_20_500_12854_65386
005 20210420
020 |a 841 
020 |a 9789533075532 
020 |a 9789535166177 
024 7 |a 10.5772/841  |c doi 
041 0 |a English 
042 |a dc 
072 7 |a MJCL  |2 bicssc 
100 1 |a Antica, Mariastefania  |4 edt 
700 1 |a Antica, Mariastefania  |4 oth 
245 1 0 |a Acute Leukemia : The Scientist's Perspective and Challenge 
260 |b IntechOpen  |c 2011 
300 |a 1 electronic resource (442 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a This book provides a comprehensive overview of he basic mechanisms underlying areas of acute leukemia, current advances, and future directions in management of this disease. The first section discusses the classification of acute leukemia, taking into account diagnoses dependent on techniques that are essential, and thankfully readily available, in the laboratory. The second section concerns recent advances in molecular biology, markers, receptors, and signaling molecules responsible for disease progression, diagnostics based on biochips and other molecular genetic analysis. These advances provide clinicians with important understanding and improved decision making towards the most suitable therapy for acute leukemia. Biochemical, structural, and genetic studies may bring a new era of epigenetic based drugs along with additional molecular targets that will form the basis for novel treatment strategies. Later in the book, pediatric acute leukemia is covered, emphasizing that children are not small adults when it comes to drug development. The last section is a collection of chapters about treatment, as chemotherapy-induced toxicity is still a significant clinical concern. The present challenge lies in reducing the frequency and seriousness of adverse effects while maintaining efficacy and avoiding over-treatment of patients. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Oncology  |2 bicssc 
653 |a Oncology 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/318/authors_book/authors_book.pdf  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/65386  |7 0  |z DOAB: description of the publication